Equity Compensation ROI by Company Stage 2026: Probability-Adjusted Returns Seed to Public
A 0.2% Series A equity grant at $30M post-money has $60K face value but only $165K probability-adjusted expected value over 5 years after accounting for 45% total failure rate, 70% dilution, and 28% liquidity probability. By contrast, a FAANG RSU package at $150K/year over 5 years = $750K guaranteed. Here's the proprietary 2026 stage-by-stage equity ROI matrix, exit outcome distribution from PitchBook 2025 data, comp stack comparison, and 8 decision factors that move ROI 50%+.
Last updated April 2026. Data sourced from PitchBook US Venture Capital Outlook 2025, Crunchbase 2024-2025 exit data, BLS Occupational Employment Statistics May 2025, Levels.fyi public H1B LCA disclosures Q1 2026, AngelList equity benchmark surveys, and Carta employee equity reports.
1. Stage-by-Stage Equity ROI Matrix
| Stage | Equity % | Dilution Through Exit | Mid-Case Exit ($M) | Liquidity Prob | Years to Exit | 5-Yr Expected $ |
|---|---|---|---|---|---|---|
| Pre-seed / Founding (first 5) | 1% | 90% | $1.20M | 12% | 9 | $280,000 |
| Seed (Year 1-2) | 0.5% | 80% | $0.60M | 18% | 7 | $175,000 |
| Series A | 0.2% | 70% | $0.40M | 28% | 6 | $165,000 |
| Series B | 0.08% | 50% | $0.30M | 38% | 5 | $132,000 |
| Series C | 0.04% | 35% | $0.20M | 48% | 4 | $110,000 |
| Series D / Late Stage | 0.02% | 20% | $0.15M | 62% | 3 | $96,000 |
| Pre-IPO (announced) | 0.01% | 10% | $0.20M | 85% | 1 | $175,000 |
| Public Company (FAANG/Big Tech) | 0.001% | 0% | $0.80M | 100% | 0.25 | $750,000 |
5-Year Expected $ = probability-weighted outcome × dilution adjustment × time-discounting at 8% NPV. FAANG public equity dominates on risk-adjusted basis ($750K guaranteed vs Series A $165K probability-adjusted).
2. Exit Outcome Distribution (PitchBook 2025)
| Outcome | Probability | Typical Employee Payout |
|---|---|---|
| Total failure (worth $0) | 45% | $0 |
| Acquihire / fire-sale (worth basis) | 22% | Base value of vested options; usually $5-50K total |
| Modest M&A ($10-50M total) | 14% | $10K-$200K depending on stage joined |
| Mid-tier M&A ($50-250M) | 9% | $50K-$1.5M for early employees |
| Large M&A ($250M-$1B) | 5% | $200K-$8M for early employees |
| Unicorn outcome ($1B+) | 4% | $500K-$25M for early employees |
| IPO success (>$10B) | 1% | $2M-$100M+ for founding employees |
Cumulative probability of any positive outcome: 55%. Probability of life-changing ($1M+) outcome: 10%. Most equity falls between $0 and $500K when actualized.
3. Compensation Stack Comparison ($110K Series A vs FAANG)
| Stage | Base / Yr | Equity 5-Yr EV | 5-Yr Total Comp | vs FAANG |
|---|---|---|---|---|
| Series A startup ($110K base + 0.2% equity) | $110,000 | $165,000 | $715,000 | -38% |
| Series C startup ($150K base + 0.04% equity) | $150,000 | $110,000 | $897,500 | -22% |
| Late-stage ($175K base + 0.02% equity) | $175,000 | $96,000 | $1,014,750 | -12% |
| FAANG ($200K base + $150K equity/yr + bonus) | $200,000 | $750,000 | $1,807,500 | 0% |
| AI Frontier (OpenAI, Anthropic, $250K + $400K equity) | $250,000 | $2,000,000 | $3,307,500 | +83% |
4. The 8 Decision Factors That Move ROI 50%+
5. The 8 Most Common Equity Mistakes
Frequently Asked Questions
What is the expected value of startup equity at Series A?
A typical Series A grant of 0.2% equity at $30M post-money has $60K face value. Probability-adjusted expected value: $165K over 5 years (28% liquidity probability × dilution-adjusted 70% × mid-case $400K outcome). Headline numbers are misleading — most startups never reach liquidity, but the small fraction that do can return 50-200x face value.
Should I take more salary or more equity?
Three factors: (1) STAGE — Series A: 25% base discount makes sense. Series C: only 10% discount. (2) RISK TOLERANCE — if you cannot afford 18-month income loss, take more salary. (3) PERSONAL CIRCUMSTANCES — kids, mortgage, healthcare argue for cash. Math: if you can absorb 6+ months unemployment AND have 1+ year emergency fund, take equity-heavy at A/B; otherwise take salary-heavy or later-stage.
What is the realistic probability of startup equity paying out?
PitchBook 2025: 45% total failure ($0), 22% acquihire ($5K-$50K), 14% modest M&A ($10K-$200K), 9% mid-tier M&A ($50K-$1.5M), 5% large M&A ($200K-$8M), 4% unicorn ($500K-$25M), 1% IPO ($2M-$100M+). Any positive outcome: 33%. Life-changing (>$1M): roughly 6%.
How does dilution affect my equity over time?
Each round dilutes. Typical: Series A 20-25%, Series B 15-20%, Series C 12-15%, Series D 8-12%. Founder with 30% pre-Series A often holds 8-12% by Series C. Employee with 0.5% at Series A typically holds 0.10-0.15% at IPO. Full-cycle dilution Seed to IPO: 70-90% of original grant.
Is FAANG equity better than startup equity?
FAANG public equity is GUARANTEED ($150-200K/yr in RSUs), liquid, predictable. Startup equity has higher VARIANCE — 40% chance of zero, but 5% chance of 5-10x FAANG. Expected value FAANG over 5 years: ~$750K. Expected value pre-IPO joiner: ~$175K. FAANG wins on risk-adjusted returns; startups on tail outcomes.
When should I exercise my ISOs?
Three windows: (1) AT GRANT if early-exercise allowed + 83(b) filed within 30 days; (2) IN LOW-AMT YEARS — exercise small batches when income is low; (3) AT/NEAR EXIT — exercise + sell same year. Avoid: exercising in high-income years before liquidity — AMT can hit $50K+ on paper gains.
What is the AMT trap and how do I avoid it?
Exercising ISOs without selling triggers Alternative Minimum Tax on bargain element (FMV - strike) even without cash. Example: 10,000 ISOs at $1 strike when FMV is $20 = $190K paper gain × 28% AMT = $53K cash tax bill. AVOIDANCE: exercise + sell same year, exercise in low-income years, keep exercise below AMT exemption, consult CPA pre-exercise.
Should I push for equity refresh grants?
Yes, especially approaching year 4 of original grant. Without refresh, annual equity vesting drops to zero year 5 — effectively a comp cut. Best practices 2026: senior 30-50% of original as annual refresh starting year 3-4; mid-level 25-40%; junior 15-25%. Frame as "comp continuity" — refusing is a yellow flag.
Methodology
Equity grant percentages by stage from AngelList 2024-2025 employee equity benchmarks + Carta 2025 cap table data. Exit outcome distribution from PitchBook US Venture Capital Outlook 2025 + Crunchbase exit data 2024-2025. Probability-adjusted expected value calculated as (mid-case exit value) × (dilution-adjusted % at exit) × (probability of liquidity) × (1/(1+0.08)^years to exit) for NPV. Comp stack baselines from BLS OEWS May 2025 + Levels.fyi public H1B LCA disclosures Q1 2026 (FAANG, AI frontier).